Related references
Note: Only part of the references are listed.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Minimal Clinically Important Differences in Pharmacological Trials
Paul W. Jones et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Long-Acting Bronchodilators and Arterial Stiffness in Patients With COPD
Jean-Louis Pepin et al.
CHEST (2014)
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
Dave Singh et al.
BMC PULMONARY MEDICINE (2014)
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
Marc L. Decramer et al.
LANCET RESPIRATORY MEDICINE (2013)
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
Roland Buhl et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
R. Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Claus Vogelmeier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease Indacaterol Versus Tiotropium
James F. Donohue et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD
D-W. Perng et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone
Kazuyoshi Kurashima et al.
RESPIROLOGY (2009)
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
Jadwiga A. Wedzicha et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Outcomes for COPD pharmacological trials:: from lung function to biomarkers
M. Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
Claus Vogelmeier et al.
RESPIRATORY MEDICINE (2008)
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials
S. D. Aaron et al.
THORAX (2008)
Exacerbations of chronic obstructive pulmonary disease
B. R. Celli et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease
S Suissa
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
NC Barnes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Global burden of COPD: systematic review and meta-analysis
R. J. Halbert et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
JJ Soler-Cataluña et al.
THORAX (2005)
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study):: a prevalence study
AMB Menezes et al.
LANCET (2005)
Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD
DD Briggs et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2005)
COPD exacerbations:: the importance of a standard definition
R Pauwels et al.
RESPIRATORY MEDICINE (2004)
Impact of preventing exacerbations on deterioration of health status in COPD
S Spencer et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study
M Miravitlles et al.
THORAX (2004)
Longitudinal changes in the nature, severity and frequency of COPD exacerbations
GC Donaldson et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
V Brusasco et al.
THORAX (2003)
Interpreting COPD prevalence estimates: What is the true burden of disease?
RJ Halbert et al.
CHEST (2003)
Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue
MJ Gizycki et al.
THORAX (2002)
Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD
M Miravitlles et al.
CHEST (2002)
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD
S Gompertz et al.
THORAX (2001)
Share Paper
